Successful desensitization after hypersensitivity reaction to cisplatin
in a patient with nasopharyngeal carcinoma
Hypersensitivity reaction (HSR) to cisplatin can result in
discontinuation of chemoradiotherapy in patients with head and neck
squamous cell carcinoma (HNSCC). We present a nasopharyngeal carcinoma
patient with cisplatin hypersensitivity successfully treated with
cisplatin-desensitization. Desensitization therapy may be safe and
beneficial in patients with HNSCC who develop HSR to cisplatin.